Retention profile and selective separation of 90Y from 89Sr using zirconium-vanadate gel packed column

被引:0
作者
M. S. El-Shahawi
M. W. Kadi
S. H. El-Khouly
A. Abd El-Mohty
S. M. Saad
N. E. A. Eweda
机构
[1] Damiatta University,Department of Chemistry, Faculty of Science
[2] King Abdulaziz University,Department of Chemistry, Faculty of Science
[3] Hot Labs Center,Department of Radioactive Isotopes and Generators
[4] Atomic Energy Authority,Cyclotron Project
[5] Nuclear Research Center,undefined
[6] Atomic Energy Authority,undefined
来源
Journal of Radioanalytical and Nuclear Chemistry | 2013年 / 295卷
关键词
Separation; Y generator; Zirconium-vanadate (Zr-V) gel ion exchanger; Column chromatography; Radiochemical and radionuclide purity;
D O I
暂无
中图分类号
学科分类号
摘要
A low cost and selective method has been developed for the separation of trace concentrations of 90Y3+ from its parent 89Sr2+. The proposed procedure is based upon complete retention of 90Y3+ onto zirconium-vanadate (Zr-V) gel ion exchanger packed column from aqueous solutions containing HCl (1.0 × 10−5mol dm−3). Under these conditions, 89Sr2+ species were not retained onto Zr-V sorbent. The retained 90Y3+ species were then recovered with HCl. The performance of Zr-V sorbent packed column was determined via the height equivalent to the theoretical plates (HETP) and the number of plates (N). Validation of the developed method was checked by calculating the radionuclidic purity in terms of purification factor (Pf = A/A0) and radiochemical purity of the eluted 90Y from the column. Zr-V sorbent packed column offers unique advantages of retention and quantitative separation of 90Y from retention over conventional solid sorbents in rapid and effective separation of trace concentration of 90Y3+ from 89Sr2+ in their aqueous equilibrium media.
引用
收藏
页码:1873 / 1880
页数:7
相关论文
共 107 条
  • [1] Govindan SV(2010)New antibody conjugates in cancer therapy Sci World J 10 2070-2089
  • [2] Goldenberg DM(2012)FDG-PET-CT and whole-body MRI for triagwe in patients planned for radiombolisation theraby Eur J Radiol 81 269-276
  • [3] Schmidt GP(2012)The workshop on signatures of medical and industrial isotope production -WOSMIP; Strassoldo, Italy, 1–3 July 2009 J Environ Radioact 110 1-6
  • [4] Paprottka P(2004)Radioimmunotherapy of non-Hodgkin’s lymphoma: clinical development of the Zevalin regimen Biotechnol Annu Rev 10 265-295
  • [5] Jakobs TF(2011)Preferential extraction of 90Y from 90Sr using J Radioanal Nucl Chem 288 389-394
  • [6] Hoffmann RT(2011), Appl Radiat Isot 69 158-162
  • [7] Baur-Melnyk A(1218), J Chromatogr A 6483–6488 2011-1877
  • [8] Haug A(2009), Appl Radiat Isot 67 1874-942
  • [9] Matthews KM(2010)-tetra-2-ethylhexyl diglycolamide (T2EHDGA) as the extractant Nucl Med Biol 37 935-12
  • [10] Bowyer TW(2012)Separation of 90Y from 90Sr by a solvent extraction method using World J Nucl Sci Technol 1 6-93